Allopurinol long term effect

The prognosis in APRT deficiency clearly depends on the renal function at the time of diagnosis. This underlines the importance of early recognition and appropriate treatment. Allopurinol, — without alkali— will inhibit the formation of the nephrotoxic 2,8-DHA, and thus effectively prevent what should be an essentially benign disorder becoming a potentially lethal one. The long-term effect of allopurinol therapy with its potential for adenine accumulation, particularly in those cases with severe renal damage, remains to be established. All supposed uric acid stones should be submitted for analysis by special techniques to avoid any further confusion in the future. 

Phenytoin (Dilantin) [Anticenvulsant/Hydantoin] Uses Sz disorders Action X Sz spread in the motor cortex Dose Load Adults Peds. 15-20 mg/kg IV, 25 mg/min max or PO in 400-mg doses at 4-h intervals Maint Adults. Initial, 200 mg PO or IV bid or 300 mg hs then follow levels Peds. 4-7 mg/kg/24h PO or IV -s- daily-bid avoid PO susp (erratic absorption) Caution [D, +] Contra Heart block, sinus bradycardia Disp Caps, susp, inj SE Nystag-mus/ataxia early signs of tox gum hyperplasia w/ long-term use. IV BP, bradycardia, arrhythmias, phlebitis peripheral neuropathy, rash, blood dyscrasias, Stevens-Johnson synd Notes Levels Trough Just before next dose Therapeutic Peak 10-20 mcg/mL Toxic >20 mcg/mL phenytoin albumin bound, levels = bound free phenytoin w/ i albumin azotemia, low levels may be therapeutic (nl free levels) Interactions T Effects W/ amiodarone, allopurinol, chloramphenicol, disulfiram, INH, omeprazole, sulfonamides, quinolones, trimethoprim t... 

Allopurinol itself is metabolized by xanthine oxidase to form the active metabolite oxypurtnol, which tends to accumulate after chronic administration of the parent drug. This phenomenon contributes to the therapeutic effectiveness of allopurinol in long-term use. Oxypurinol is probably responsible for the antigout effects of allopurinol. Oxypurinol itself is not administered because it is not well absorbed orally. 

CARBAMAZEPINE ANTIGOUT DRUGS -ALLOPURINOL High-dose allopurinol (600mg/day) may t carbamazepine levels over a period of several weeks. 300 mg/ day allopurinol does not seem to have this effect Uncertain Monitor carbamazepine levels in patients taking long-term, high-dose allopurinol... 

Rosenfeld JB. Effect of long-term allopurinol administraton on serial GFR In normotensive and hypertensive hyperuricemic subjects. Adv Exp Med Biol 1974 41 581-596. 

Two phase III studies versus aUopurinol (n = 762 and 1067), and two long-term, open-label extension studies (n= 116 and 1086) have been reported. In a published 52-week phase III study, more febuxostat recipients achieved the primary endpoint of serum urate concentration (sUA, < 0.36mmol/L) compared to allopurinol. Despite the greater effect on sUA, there was no difference between treatments in more clinically important outcomes such as gout flares and tophi reduction (secondary endpoints). The adverse event profiles of febuxostat and allopurinol were similar over the 52-week period. Longterm adverse event data for febuxostat (1) is limited. 

EFFECT OF LONG-TERM ALLOPURINOL AmiNISTRaTION ON SERIAL GFR IN NORMOTENSIVE AND HYPERTl SIVE HYPERURICMIC SUBJECTS... 

Effect of Long-Term Allopurinol Administration on Serial GFR in Normotensive and... 

---